REVIEW
|
doi:10.20944/preprints202306.1898.v1
Subject:
Medicine And Pharmacology,
Hematology
Keywords:
chronic lymphocytic leukemia; older patient; ibrutinib; acalabrutinib; zanubrutinib; venetoclax; sustainabiity
Online: 27 June 2023 (12:04:57 CEST)